Download PDF
Horm Metab Res 2022; 54(02): 104-112
DOI: 10.1055/a-1730-5251
Endocrine Care

Association Between Prediabetes and Osteoarthritis: A Meta-Analysis

Xi Li
1   Department of Traumatology Orthopedics, The People’s Hospital of Longhua District of Shenzhen, Shenzhen, China
,
Yong Zhou
1   Department of Traumatology Orthopedics, The People’s Hospital of Longhua District of Shenzhen, Shenzhen, China
,
Jianxiu Liu 
1   Department of Traumatology Orthopedics, The People’s Hospital of Longhua District of Shenzhen, Shenzhen, China
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Some studies have suggested that diabetes may be a risk factor for osteoarthritis. However, whether prediabetes is also associated with osteoarthritis has not been comprehensively examined. We performed a meta-analysis to evaluate the relationship between prediabetes and osteoarthritis. This meta-analysis included relevant observational studies from Medline, Embase, and Web of Science databases. A random-effect model after incorporation of the intra-study heterogeneity was selected to pool the results. Ten datasets from six observational studies were included, which involved 41 226 general adults and 10 785 (26.2%) of them were prediabetic. Pooled results showed that prediabetes was not independently associated with osteoarthritis [risk ratio (RR): 1.07, 95% confidence interval (CI): 1.00 to 1.14, p=0.06, I2=0%]. Sensitivity limited to studies with adjustment of age and body mass index showed consistent result (RR: 1.06, 95% CI: 0.99 to 1.14, p=0.09, I2=0%). Results of subgroup analyses showed that prediabetes was not associated with osteoarthritis in cross-sectional or cohort studies, in studies including Asian or non-Asian population, or in studies with different quality scores (p for subgroup difference>0.10). Besides, prediabetes was not associated with osteoarthritis in men or in women, in studies with prediabetes defined as impaired fasting glucose, impaired glucose tolerance, or HbA1c (approximately 39–46 mmol/mol). Moreover, prediabetes was not associated with overall osteoarthritis, and knee or hip osteoarthritis. Current evidence does not support that prediabetes is independently associated with osteoarthritis in adult population.

Key words

osteoarthritis - prediabetes - pbservational studies - meta-analysis


Publication History

Received: 08 December 2021

Accepted after revision: 27 December 2021

Article published online:
07 February 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet 2019; 393: 1745-1759
    CrossrefPubMedGoogle Scholar
  • 2 Quicke JG, Conaghan PG, Corp N. et al. Osteoarthritis year in review 2021: epidemiology & therapy. Osteoarthritis Cartilage 2021; DOI: 10.1016/j.joca.2021.10.003.
    CrossrefPubMedGoogle Scholar
  • 3 Louati K, Vidal C, Berenbaum F. et al. Association between diabetes mellitus and osteoarthritis: systematic literature review and meta-analysis. RMD Open 2015; 1: e000077
    CrossrefPubMedGoogle Scholar
  • 4 Williams MF, London DA, Husni EM. et al. Type 2 diabetes and osteoarthritis: a systematic review and meta-analysis. J Diabetes Complicat 2016; 30: 944-950
    CrossrefPubMedGoogle Scholar
  • 5 Khor A, Ma CA, Hong C. et al. Diabetes mellitus is not a risk factor for osteoarthritis. RMD Open 2020; 6: e001030
    CrossrefPubMedGoogle Scholar
  • 6 Cannata F, Vadala G, Ambrosio L. et al. Osteoarthritis and type 2 diabetes: from pathogenetic factors to therapeutic intervention. Diabetes Metab Res Rev 2020; 36: e3254
    CrossrefPubMedGoogle Scholar
  • 7 King KB, Rosenthal AK. The adverse effects of diabetes on osteoarthritis: update on clinical evidence and molecular mechanisms. Osteoarthritis Cartilage 2015; 23: 841-850
    CrossrefPubMedGoogle Scholar
  • 8 Njoto I, Kalim H, Soeatmadji DW. et al. Effect of hyperglycemia to the mRNA level and protein expression of perlecan at rat model of osteoarthritis with diabetes mellitus type 1. Med Arch 2019; 73: 144-148
    CrossrefPubMedGoogle Scholar
  • 9 Minton DM, Elliehausen CJ, Javors MA. et al. Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis. Arthritis Res Ther 2021; 23: 253
    CrossrefPubMedGoogle Scholar
  • 10 Cho NH, Shaw JE, Karuranga S. et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018; 138: 271-281
    CrossrefPubMedGoogle Scholar
  • 11 Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018; 14: 88-98
    CrossrefPubMedGoogle Scholar
  • 12 Allen KD, Thoma LM, Golightly YM. Epidemiology of osteoarthritis. Osteoarthritis Cartilage 2021; S1063-4584(21)00886-4 DOI: 10.1016/j.joca.2021.04.020.
    CrossrefPubMedGoogle Scholar
  • 13 Tabak AG, Herder C, Rathmann W. et al. Prediabetes: a high-risk state for diabetes development. Lancet 2012; 379: 2279-2290
    CrossrefPubMedGoogle Scholar
  • 14 Guasch-Ferre M, Hruby A. et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care 2016; 39: 833-846
    CrossrefPubMedGoogle Scholar
  • 15 Rajpal A, Ismail-Beigi F. Intermittent fasting and ‘metabolic switch’: Effects on metabolic syndrome, prediabetes and type 2 diabetes. Diabetes Obes Metab 2020; 22: 1496-1510
    CrossrefPubMedGoogle Scholar
  • 16 Sallar A, Dagogo-Jack S. Regression from prediabetes to normal glucose regulation: state of the science. Exp Biol Med (Maywood) 2020; 245: 889-896
    CrossrefPubMedGoogle Scholar
  • 17 Hostalek U. Global epidemiology of prediabetes – present and future perspectives. Clin Diabetes Endocrinol 2019; 5: 5
    CrossrefPubMedGoogle Scholar
  • 18 Chatterton H, Younger T, Fischer A. et al. Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance. BMJ 2012; 345: e4624
    CrossrefPubMedGoogle Scholar
  • 19 [Anonymous] Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care 2019; 42: S13-S28
    CrossrefPubMedGoogle Scholar
  • 20 Cai X, Zhang Y, Li M. et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ 2020; 370: m2297
    CrossrefPubMedGoogle Scholar
  • 21 Huang Y, Cai X, Chen P. et al. Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med 2014; 46: 684-692
    CrossrefPubMedGoogle Scholar
  • 22 Luc K, Schramm-Luc A, Guzik TJ. et al. Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol 2019; 70 DOI: 10.26402/jpp.2019.6.01. Epub 2020 Feb 19
    CrossrefPubMedGoogle Scholar
  • 23 Dawson LP, Fairley JL, Papandony MC. et al. Is abnormal glucose tolerance or diabetes a risk factor for knee, hip, or hand osteoarthritis? A systematic review. Semin Arthritis Rheum 2018; 48: 176-189
    CrossrefPubMedGoogle Scholar
  • 24 Page MJ, McKenzie JE, Bossuyt PM. et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71
    CrossrefPubMedGoogle Scholar
  • 25 Page MJ, Moher D, Bossuyt PM. et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021; 372: n160
    CrossrefPubMedGoogle Scholar
  • 26 Higgins J, Thomas J, Chandler J. et al. Cochrane handbook for systematic reviews of interventions version 6.2. The Cochrane collaboration. 2021 www.training.cochrane.org/handbook
    Google Scholar
  • 27 Wells GA, Shea B, O’Connell D. et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2010 http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  • 28 Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558
    CrossrefPubMedGoogle Scholar
  • 29 Piva SR, Susko AM, Khoja SS. et al. Links between osteoarthritis and diabetes: implications for management from a physical activity perspective. Clin Geriatr Med 2015; 31: 67-87 viii
    CrossrefPubMedGoogle Scholar
  • 30 Egger M, Davey Smith G, Schneider M. et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
    CrossrefPubMedGoogle Scholar
  • 31 Frey MI, Barrett-Connor E, Sledge PA. et al. The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study. J Rheumatol 1996; 23: 716-722
    PubMedGoogle Scholar
  • 32 Martin K, Lethbridge-Cejku M, Muller DC. et al. Metabolic correlates of obesity and radiographic features of knee osteoarthritis: data from the Baltimore longitudinal study of aging. J Rheumatol 1997; 24: 702-707
    PubMedGoogle Scholar
  • 33 Yoshimura N, Muraki S, Oka H. et al. Accumulation of metabolic risk factors such as overweight, hypertension, dyslipidaemia, and impaired glucose tolerance raises the risk of occurrence and progression of knee osteoarthritis: a 3-year follow-up of the ROAD study. Osteoarthritis Cartilage 2012; 20: 12171226
    CrossrefPubMedGoogle Scholar
  • 34 Monira Hussain S, Wang Y. et al. Incidence of total knee and hip replacement for osteoarthritis in relation to the metabolic syndrome and its components: a prospective cohort study. Semin Arthritis Rheum 2014; 43: 429-436
    CrossrefPubMedGoogle Scholar
  • 35 Kim HS, Shin JS, Lee J. et al. Association between knee osteoarthritis, cardiovascular risk factors, and the Framingham risk score in South Koreans: a cross-sectional study. PLoS One 2016; 11: e0165325
    CrossrefPubMedGoogle Scholar
  • 36 Zhu Z, Sheng X, Zhang J. et al. Association between type 2 diabetes status and osteoarthritis in adults aged ≥ 50 years. J Orthop Sci 2021; S0949-2658(20)30364-X DOI: 10.1016/j.jos.2020.12.001.
    CrossrefPubMedGoogle Scholar
  • 37 Veronese N, Cooper C, Reginster JY. et al. Type 2 diabetes mellitus and osteoarthritis. Semin Arthritis Rheum 2019; 49: 9-19
    CrossrefPubMedGoogle Scholar